Frank Pk Hsu, MD | |
101 The City Dr S, Orange, CA 92868-3201 | |
(714) 456-6966 | |
Not Available |
Full Name | Frank Pk Hsu |
---|---|
Gender | Male |
Speciality | Neurosurgery |
Experience | 29 Years |
Location | 101 The City Dr S, Orange, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548298417 | NPI | - | NPPES |
00G868910 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | G86891 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of California Irvine Medical Center | Orange, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regents Of The University Of California | 4082510250 | 19 |
News Archive
State organizers are creating obstacles to national health care reform. In Colorado, Republican organizer Jon Caldara has vowed to derail national reforms with a ballot initiative. The Wall Street Journal reports about similar steps being taken across the country. "Republican attorneys general and governors ... are threatening to file suit to block a particular provision of the Senate bill that gives a special financial deal to Nebraska.
Hollywood talent manager Louis Bershad, 68, whose clients include many top actors in town, recently underwent a routine MRI for kidney stones only to learn from his urologist that he also had a tumor in his left kidney.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.
SARcode Corporation presented data today for their lead investigational molecule, SAR 1118. In a Phase 2 dry eye trial, subjects receiving SAR 1118 demonstrated a reduction in corneal staining, increased tear production, and improved visual-related function as compared to placebo. These data were part of the scientific program of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Fort Lauderdale, Florida.
› Verified 4 days ago
Entity Name | Regents Of The University Of California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659329746 PECOS PAC ID: 4082510250 Enrollment ID: O20031209000514 |
News Archive
State organizers are creating obstacles to national health care reform. In Colorado, Republican organizer Jon Caldara has vowed to derail national reforms with a ballot initiative. The Wall Street Journal reports about similar steps being taken across the country. "Republican attorneys general and governors ... are threatening to file suit to block a particular provision of the Senate bill that gives a special financial deal to Nebraska.
Hollywood talent manager Louis Bershad, 68, whose clients include many top actors in town, recently underwent a routine MRI for kidney stones only to learn from his urologist that he also had a tumor in his left kidney.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.
SARcode Corporation presented data today for their lead investigational molecule, SAR 1118. In a Phase 2 dry eye trial, subjects receiving SAR 1118 demonstrated a reduction in corneal staining, increased tear production, and improved visual-related function as compared to placebo. These data were part of the scientific program of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Fort Lauderdale, Florida.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Frank Pk Hsu, MD 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-6966 | Frank Pk Hsu, MD 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-6966 |
News Archive
State organizers are creating obstacles to national health care reform. In Colorado, Republican organizer Jon Caldara has vowed to derail national reforms with a ballot initiative. The Wall Street Journal reports about similar steps being taken across the country. "Republican attorneys general and governors ... are threatening to file suit to block a particular provision of the Senate bill that gives a special financial deal to Nebraska.
Hollywood talent manager Louis Bershad, 68, whose clients include many top actors in town, recently underwent a routine MRI for kidney stones only to learn from his urologist that he also had a tumor in his left kidney.
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that it has received a subpoena from the Office of Inspector General ("OIG") of the Department of Health and Human Services ("HHS") in connection with a civil investigation into matters primarily related to the Company's sales and marketing activities.
SARcode Corporation presented data today for their lead investigational molecule, SAR 1118. In a Phase 2 dry eye trial, subjects receiving SAR 1118 demonstrated a reduction in corneal staining, increased tear production, and improved visual-related function as compared to placebo. These data were part of the scientific program of the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Fort Lauderdale, Florida.
› Verified 4 days ago
Michelle Paff, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-880-7812 | |
Dr. Maheen Qamar Khan, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-6966 | |
Ichiro Yuki, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S # I, Orange, CA 92868 Phone: 714-456-6966 | |
Dr. Joseph Daniel Lockwood, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 200 S Manchester Ave Ste 210, Orange, CA 92868 Phone: 870-674-4555 | |
Dr. Michael Y Oh, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 101 The City Dr S Bldg 30, Orange, CA 92868 Phone: 714-456-6966 Fax: 714-456-8212 | |
John A Kusske, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-8978 | |
Michael Kim, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 S Manchester Ave Ste 210, Orange, CA 92868 Phone: 714-456-7495 |